|
US5457038A
(en)
|
1988-11-10 |
1995-10-10 |
Genetics Institute, Inc. |
Natural killer stimulatory factor
|
|
US5573764A
(en)
|
1994-01-21 |
1996-11-12 |
Genetics Institute, Inc. |
Use of interleukin-12 to prevent graft versus host disease
|
|
US5891680A
(en)
|
1995-02-08 |
1999-04-06 |
Whitehead Institute For Biomedical Research |
Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
EP1489100B1
(en)
|
1997-12-08 |
2016-06-15 |
Merck Patent GmbH |
Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
|
|
US6682736B1
(en)
|
1998-12-23 |
2004-01-27 |
Abgenix, Inc. |
Human monoclonal antibodies to CTLA-4
|
|
JP4793971B2
(ja)
|
1999-08-09 |
2011-10-12 |
メルク パテント ゲーエムベーハー |
複合サイトカイン−抗体複合体
|
|
IL148079A0
(en)
|
1999-08-24 |
2002-09-12 |
Medarex Inc |
Human ctla-4 antibodies and compositions containing the same
|
|
US7083970B2
(en)
|
2001-04-19 |
2006-08-01 |
The Scripps Research Institute |
Methods and compositions for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs
|
|
BRPI0408247A
(pt)
|
2003-03-10 |
2006-03-01 |
Schering Corp |
usos de antagonistas e agonistas de il-23 e reagentes relacionados
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
US8802643B1
(en)
|
2003-05-30 |
2014-08-12 |
University Of South Florida |
Method for the treatment of malignancies
|
|
US8546543B2
(en)
|
2004-11-12 |
2013-10-01 |
Xencor, Inc. |
Fc variants that extend antibody half-life
|
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
RU2494107C2
(ru)
|
2005-05-09 |
2013-09-27 |
Оно Фармасьютикал Ко., Лтд. |
Моноклональные антитела человека к белку программируемой смерти 1 (pd-1) и способы лечения рака с использованием анти-pd-1-антител самостоятельно или в комбинации с другими иммунотерапевтическими средствами
|
|
CN103145839A
(zh)
|
2005-06-30 |
2013-06-12 |
Abbvie公司 |
Il-12/p40结合蛋白
|
|
CN104356236B
(zh)
|
2005-07-01 |
2020-07-03 |
E.R.施贵宝&圣斯有限责任公司 |
抗程序性死亡配体1(pd-l1)的人单克隆抗体
|
|
BRPI0620648B1
(pt)
|
2005-12-30 |
2022-12-20 |
Merck Patent Gesellschaft Mit Beschrãnkter Haftung |
Variante de il-12 p40, proteínas il-12, il-23 e de fusão, composição farmacêutica e uso da mesma
|
|
ES2563027T3
(es)
|
2008-01-07 |
2016-03-10 |
Amgen Inc. |
Método para fabricación de moléculas heterodímeras Fc de anticuerpos utilizando efectos de conducción electrostática
|
|
WO2009114335A2
(en)
|
2008-03-12 |
2009-09-17 |
Merck & Co., Inc. |
Pd-1 binding proteins
|
|
AU2009333580B2
(en)
|
2008-12-09 |
2016-07-07 |
Genentech, Inc. |
Anti-PD-L1 antibodies and their use to enhance T-cell function
|
|
EP2389192A4
(en)
|
2009-01-23 |
2013-01-16 |
Biogen Idec Inc |
STABILIZED FC POLYPEPTIDES WITH REDUCED EFFECTOR FUNCTION AND METHOD OF USE
|
|
US9493578B2
(en)
|
2009-09-02 |
2016-11-15 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
|
US9527926B2
(en)
|
2010-05-14 |
2016-12-27 |
Rinat Neuroscience Corp. |
Heterodimeric proteins and methods for producing and purifying them
|
|
PL2635607T3
(pl)
|
2010-11-05 |
2020-05-18 |
Zymeworks Inc. |
Projekt stabilnego przeciwciała heterodimerowego z mutacjami w domenie FC
|
|
US9714291B2
(en)
|
2012-10-05 |
2017-07-25 |
Kyowa Hakko Kirin Co., Ltd |
Heterodimer protein composition
|
|
EP2970486B1
(en)
|
2013-03-15 |
2018-05-16 |
Xencor, Inc. |
Modulation of t cells with bispecific antibodies and fc fusions
|
|
PT3107573T
(pt)
|
2014-02-19 |
2019-01-10 |
Merck Patent Gmbh |
Imunoterapia com il-12 visada ao cancro
|
|
SG11201702295UA
(en)
|
2014-09-22 |
2017-04-27 |
Intrexon Corp |
Improved therapeutic control of heterodimeric and single chain forms of interleukin-12
|
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
US11087249B2
(en)
|
2016-05-24 |
2021-08-10 |
Ciambella Ltd. |
Method and apparatus for triggering execution of a workflow over a network
|
|
MX386014B
(es)
*
|
2016-08-10 |
2025-03-18 |
Univ Ajou Ind Academic Coop Found |
Citocina fusionada a fc heterodimérico, y composición farmacéutica que comprende la misma.
|
|
US10232053B2
(en)
|
2016-12-30 |
2019-03-19 |
Trieza Therapeutics, Inc. |
Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancer
|
|
SG11201907299XA
(en)
|
2017-02-08 |
2019-09-27 |
Dragonfly Therapeutics Inc |
Multi-specific binding proteins for activation of natural killer cells and therapeutic uses thereof to treat cancer
|
|
SE541511C2
(sv)
|
2017-03-06 |
2019-10-22 |
Slaettberg Fredrik |
Installationsklara vägg- och regelkassetter
|
|
CN110101843A
(zh)
|
2018-02-01 |
2019-08-09 |
北京科诺科服生物科技有限公司 |
一种抗肿瘤蛋白质及其应用
|
|
EA202091887A1
(ru)
|
2018-02-08 |
2020-10-23 |
Драгонфлай Терапьютикс, Инк. |
Комбинированная терапия рака с применением мультиспецифических связывающих белков, которые активируют естественные клетки-киллеры
|
|
CN110396133B
(zh)
|
2018-04-25 |
2021-07-23 |
免疫靶向有限公司 |
一种以白介素12为活性成分的融合蛋白型药物前体
|
|
CA3100005A1
(en)
|
2018-05-14 |
2019-11-21 |
Werewolf Therapeutics, Inc. |
Activatable cytokine polypeptides and methods of use thereof
|
|
EP3861016A2
(en)
*
|
2018-10-03 |
2021-08-11 |
Xencor, Inc. |
Il-12 heterodimeric fc-fusion proteins
|
|
AU2019366956B2
(en)
|
2018-10-23 |
2025-10-30 |
Dragonfly Therapeutics, Inc. |
Heterodimeric Fc-fused proteins
|
|
MX2022000991A
(es)
|
2019-07-25 |
2022-05-24 |
Univ Chicago |
Composiciones y metodos que comprenden agentes terapeuticos activados por proteasa.
|
|
CN115916233A
(zh)
*
|
2019-10-03 |
2023-04-04 |
Xencor股份有限公司 |
靶向IL-12异源二聚体Fc融合蛋白
|
|
EP4090674A4
(en)
|
2020-01-14 |
2024-01-24 |
Synthekine, Inc. |
Biased il2 muteins methods and compositions
|
|
CN121319219A
(zh)
|
2020-01-14 |
2026-01-13 |
辛德凯因股份有限公司 |
Il2突变蛋白
|
|
IL297186A
(en)
|
2020-04-17 |
2022-12-01 |
Univ Leland Stanford Junior |
Transgenic il-12 and il-23 polypeptides and their uses
|
|
US20230272041A1
(en)
|
2020-04-22 |
2023-08-31 |
Dragonfly Therapeutics, Inc. |
Formulation, Dosage Regimen, and Manufacturing Process for Heterodimeric FC-Fused Proteins
|
|
CA3217079A1
(en)
|
2021-05-05 |
2022-11-10 |
Michael Schmidt |
Fusion polypeptides
|
|
JP2024540938A
(ja)
*
|
2021-10-20 |
2024-11-06 |
シンセカイン インコーポレイテッド |
ヒトＩＬ－１２ｐ４０バリアントおよびその使用
|
|
JP2024539139A
(ja)
|
2021-10-20 |
2024-10-28 |
シンセカイン インコーポレイテッド |
ヘテロ二量体ｆｃサイトカインおよびその使用
|